Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum | Clinical Trials | Clareo Health

Back to search

COMPLETED

Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum

NCT04628169•Assiut University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pathophysiology of Placenta Accreta

Interventions

no intervention applied

Locations

Egypt

Locations (1)

Hanaa Mohammed Mohammed Sayed

Asyut, Egypt

Key Dates

Start Date

January 1, 2021

Primary Completion Date

January 1, 2023

Completion Date

July 1, 2023

Last Updated

September 20, 2024

Sponsors

Lead Sponsor

Assiut University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 20, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions